Sorrento Therapeutics stock is a buy on the 50% chance of a COVID-19 antidote, analyst says
May 26, 2020 at 14:37 PM EDT
Shares of Sorrento Therapeutics Inc. rallied Tuesday, after a Wall Street analyst suggested the biopharmaceutical company was a good bet to successfully develop an “antibody cocktail” that could shield people from the COVID-19 virus.
